🎯 check AZD6244 (Selumetinib) product page
AZD6244 is a potent ATP-uncompetitive MEK1/2 inhibitor. It affects MAPK/ERK signaling by blocking ERK, inhibiting tumor growth.
AZD6244 (Selumetinib): Mechanism of Action
AZD6244 (Selumetinib) MOA：Targeting MEK1/2/MAPK Pathway for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
Jump to
- AZD6244 (Selumetinib) Clinical Trials
- AZD6244 (Selumetinib): Selectivity & Specificity
- AZD6244 (Selumetinib) Working Concentration | Cell Culture | Treatment
- AZD6244 (Selumetinib) Solubility in DMSO
- AZD6244 (Selumetinib) Stock Solution
- AZD6244 (Selumetinib) Storage
- AZD6244 (Selumetinib) Stability
- AZD6244 (Selumetinib) Combination Database
- AZD6244 (Selumetinib) Molecular Weight
- AZD6244 (Selumetinib) SMILES
- AZD6244 (Selumetinib) CAS Number
- AZD6244 (Selumetinib) Chemical Structure (2D and 3D)
- AZD6244 (Selumetinib) IC50 for Cell-based and Cell-free Assays
- AZD6244 (Selumetinib) Sigma (sml3800)? Try a better option.
- AZD6244 (Selumetinib) MedChemExpress (HY-50706)? Try a better option.
- AZD6244 (Selumetinib) Cayman (11599)? Try a better option.
- AZD6244 (Selumetinib) APExBIO (A8207)? Try a better option.
- AZD6244 (Selumetinib) SDS｜MSDS